Skip to main content
Susanne Baumeister, MD, Pediatric Hematology & Oncology, Boston, MA, Dana-Farber Cancer Institute

SusanneBaumeisterMD

Pediatric Hematology & Oncology Boston, MA

Clinical Fellow in Pediatrics, Boston Children's Hospital

Dr. Baumeister is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Baumeister's full profile

Already have an account?

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2009 - 2012
  • University of Washington
    University of WashingtonResidency, Pediatrics, 2006 - 2009
  • Brown University
    Brown UniversityInternship, Transitional Year, 2005 - 2006
  • Ludwig Maximilian University of Munich Faculty of Medicine
    Ludwig Maximilian University of Munich Faculty of MedicineClass of 2004

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2009 - 2024
  • WA State Medical License
    WA State Medical License 2006 - 2009
  • RI State Medical License
    RI State Medical License 2005 - 2006
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia
    Susanne H.C. Baumeister, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Childhood Cancer Awareness Month: 2020 Immunotherapy Research Updates
    Childhood Cancer Awareness Month: 2020 Immunotherapy Research UpdatesSeptember 24th, 2020
  • Combining CAR-T Cells and Inhibitor Drugs for High-Risk Neuroblastoma
    Combining CAR-T Cells and Inhibitor Drugs for High-Risk NeuroblastomaFebruary 17th, 2024

Hospital Affiliations